Mackay Shields LLC’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-19,100
Closed -$2.48M – 1126
2021
Q1
$2.48M Sell
19,100
-7,500
-28% -$962K 0.02% 682
2020
Q4
$3.19M Buy
26,600
+16,500
+163% +$1.62M 0.02% 643
2020
Q3
$754K Sell
10,100
-16,621
-62% -$1.15M 0.01% 1093
2020
Q2
$1.89M Sell
26,721
-25,100
-48% -$1.72M 0.02% 786
2020
Q1
$3.4M Sell
51,821
-7,000
-12% -$558K 0.03% 467
2019
Q4
$4.81M Buy
58,821
+19,500
+50% +$1.5M 0.03% 477
2019
Q3
$2.84M Sell
39,321
-22,000
-36% -$1.61M 0.02% 755
2019
Q2
$5.28M Buy
61,321
+36,121
+143% +$2.94M 0.04% 503
2019
Q1
$2.04M Buy
+25,200
New +$1.89M 0.01% 691

Other funds holding OMCL

Mackay Shields LLC's OMCL Position: Q2 2021 in Review

Mackay Shields LLC sold out of Omnicell (OMCL) in Q2 2021, closing a stake of 19,100 shares — an estimated $2.48M sold.

Mackay Shields LLC first reported a position in OMCL in Q1 2019 and held it in 9 quarters. The position peaked at $5.28M in Q2 2019. 377 funds tracked by Wall St. Rank hold OMCL as of Q2 2021.

  • Mackay Shields LLC reported no remaining Omnicell position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 19,100 Omnicell shares in Q2 2021, an estimated $2.48M.
  • Mackay Shields LLC first reported a position in Omnicell in Q1 2019 and held it in 9 quarters.
  • Mackay Shields LLC's Omnicell position peaked at $5.28M in Q2 2019.
  • 377 funds tracked by Wall St. Rank held Omnicell as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.